2022 Q1 Form 10-Q Financial Statement

#000143774922011531 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $42.26M $41.52M
YoY Change 1.79% -21.79%
Cost Of Revenue $49.42M $52.30M
YoY Change -5.51% 42.51%
Gross Profit -$7.155M -$10.74M
YoY Change -33.36% -165.47%
Gross Profit Margin -16.93% -25.86%
Selling, General & Admin $1.773M $1.500M
YoY Change 18.2% -6.25%
% of Gross Profit
Research & Development $679.0K $774.0K
YoY Change -12.27% -7.31%
% of Gross Profit
Depreciation & Amortization $2.570M $2.608M
YoY Change -1.46% -13.18%
% of Gross Profit
Operating Expenses $2.452M $2.322M
YoY Change 5.6% -4.05%
Operating Profit -$9.607M -$13.06M
YoY Change -26.43% -193.41%
Interest Expense $32.00K $32.00K
YoY Change 0.0% -42.86%
% of Operating Profit
Other Income/Expense, Net -$3.495M -$102.0K
YoY Change 3326.47% -98.75%
Pretax Income -$13.10M -$13.16M
YoY Change -0.44% -325.69%
Income Tax -$704.0K -$4.387M
% Of Pretax Income
Net Earnings -$12.40M -$8.773M
YoY Change 41.32% -146.07%
Net Earnings / Revenue -29.34% -21.13%
Basic Earnings Per Share -$0.28 -$0.20
Diluted Earnings Per Share -$0.28 -$0.20
COMMON SHARES
Basic Shares Outstanding 43.76M 43.74M
Diluted Shares Outstanding 43.76M 43.74M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $163.7M $244.2M
YoY Change -32.95% -20.64%
Cash & Equivalents $121.0M $194.0M
Short-Term Investments $42.75M $50.20M
Other Short-Term Assets $5.712M $2.588M
YoY Change 120.71% 60.75%
Inventory $37.62M $45.28M
Prepaid Expenses $2.957M $3.216M
Receivables $18.05M $27.90M
Other Receivables $9.745M $16.80M
Total Short-Term Assets $237.8M $340.1M
YoY Change -30.07% -32.35%
LONG-TERM ASSETS
Property, Plant & Equipment $81.06M $89.20M
YoY Change -9.13% -7.99%
Goodwill
YoY Change
Intangibles $1.408M
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets $5.498M $5.721M
YoY Change -3.9% -1.58%
Total Long-Term Assets $86.55M $96.33M
YoY Change -10.15% -7.52%
TOTAL ASSETS
Total Short-Term Assets $237.8M $340.1M
Total Long-Term Assets $86.55M $96.33M
Total Assets $324.4M $436.4M
YoY Change -25.67% -28.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.99M $16.84M
YoY Change -16.92% -73.46%
Accrued Expenses $5.164M $4.568M
YoY Change 13.05% -30.81%
Deferred Revenue $6.169M $4.739M
YoY Change 30.18% 21.95%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.38M $43.03M
YoY Change -3.83% -79.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.629M $2.109M
YoY Change -22.76% -9.45%
Total Long-Term Liabilities $17.03M $30.35M
YoY Change -43.89% -21.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.38M $43.03M
Total Long-Term Liabilities $17.03M $30.35M
Total Liabilities $58.41M $73.37M
YoY Change -20.4% -70.91%
SHAREHOLDERS EQUITY
Retained Earnings -$16.60M $80.68M
YoY Change -120.57% 11.39%
Common Stock $4.000K $4.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $266.0M $363.1M
YoY Change
Total Liabilities & Shareholders Equity $324.4M $436.4M
YoY Change -25.67% -28.09%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$12.40M -$8.773M
YoY Change 41.32% -146.07%
Depreciation, Depletion And Amortization $2.570M $2.608M
YoY Change -1.46% -13.18%
Cash From Operating Activities -$10.58M -$14.35M
YoY Change -26.28% -455.65%
INVESTING ACTIVITIES
Capital Expenditures $977.0K $146.0K
YoY Change 569.18% -90.92%
Acquisitions
YoY Change
Other Investing Activities -$2.358M $12.97M
YoY Change -118.18% 137.98%
Cash From Investing Activities -$3.335M $12.83M
YoY Change -126.0% 234.24%
FINANCING ACTIVITIES
Cash Dividend Paid $2.626M $2.624M
YoY Change 0.08% 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$2.626M -$2.624M
YoY Change 0.08% -15.38%
NET CHANGE
Cash From Operating Activities -$10.58M -$14.35M
Cash From Investing Activities -$3.335M $12.83M
Cash From Financing Activities -$2.626M -$2.624M
Net Change In Cash -$16.54M -$4.143M
YoY Change 299.16% -186.84%
FREE CASH FLOW
Cash From Operating Activities -$10.58M -$14.35M
Capital Expenditures $977.0K $146.0K
Free Cash Flow -$11.55M -$14.49M
YoY Change -20.29% -697.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
86554000 USD
CY2022Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
42751000 USD
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43763243
CY2022Q1 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
5550000 USD
CY2021Q4 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
8232000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
67000 USD
CY2022Q1 ff Accounts Payable Blenders Tax Credit Payables
AccountsPayableBlendersTaxCreditPayables
890000 USD
CY2021Q4 ff Accounts Payable Blenders Tax Credit Payables
AccountsPayableBlendersTaxCreditPayables
890000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43763243
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43763243
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43763243
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43763243
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10700000 USD
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120984000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137521000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18048000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29316000 USD
CY2022Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
0 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
88497000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81056000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82901000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5498000 USD
CY2021Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
58000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
37620000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
26920000 USD
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9745000 USD
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9760000 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2957000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3588000 USD
CY2022Q1 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
12000 USD
CY2021Q4 ff Prepaid Expenses Related Parties
PrepaidExpensesRelatedParties
4000 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
47190000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
5712000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1476000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
237829000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
255833000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5596000 USD
CY2022Q1 us-gaap Assets
Assets
324383000 USD
CY2021Q4 us-gaap Assets
Assets
344330000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13992000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14912000 USD
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
7968000 USD
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
7911000 USD
CY2022Q1 ff Contract With Customer Aggregate Liability Current
ContractWithCustomerAggregateLiabilityCurrent
6376000 USD
CY2021Q4 ff Contract With Customer Aggregate Liability Current
ContractWithCustomerAggregateLiabilityCurrent
6151000 USD
CY2022Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
7877000 USD
CY2021Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5164000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6081000 USD
CY2022Q1 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
0 USD
CY2021Q4 ff Accrued Expenses And Other Current Liabilities Related Parties
AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
1000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
41377000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35056000 USD
CY2022Q1 ff Contract With Customer Aggregate Liability Noncurrent
ContractWithCustomerAggregateLiabilityNoncurrent
14261000 USD
CY2021Q4 ff Contract With Customer Aggregate Liability Noncurrent
ContractWithCustomerAggregateLiabilityNoncurrent
16755000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1138000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1870000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1629000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1721000 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17028000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
20346000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
58405000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
55402000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
129000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
178000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
282443000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
282443000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16598000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6303000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
265978000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
288928000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
324383000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
344330000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
-7155000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
-10736000 USD
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
656000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
528000 USD
CY2022Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
963000 USD
CY2021Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
853000 USD
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
154000 USD
CY2021Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
167000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
679000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
774000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2452000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2322000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9607000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13058000 USD
CY2022Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
664000 USD
CY2021Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1005000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
32000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
32000 USD
CY2022Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-4127000 USD
CY2021Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1075000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3495000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-102000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13102000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13160000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-704000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4387000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12398000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8773000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43743243
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43763243
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43743243
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12398000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8773000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-62000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-60000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-13000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-16000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-49000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-44000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12447000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8817000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
288928000 USD
CY2022Q1 us-gaap Dividends
Dividends
10503000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-49000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12398000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
265978000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
371883000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-60000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8773000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
363050000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12398000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8773000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
2570000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
2608000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
24000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
24000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-719000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4402000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4100000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1765000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1536000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
695000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-27000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
690000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 USD
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
8000 USD
CY2021Q1 us-gaap Interest Expense Other
InterestExpenseOther
8000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11268000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6515000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-58000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1375000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11389000 USD
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-15000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-774000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-631000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-751000 USD
CY2022Q1 ff Increase Decrease In Prepaid Expenses Related Parties
IncreaseDecreaseInPrepaidExpensesRelatedParties
8000 USD
CY2021Q1 ff Increase Decrease In Prepaid Expenses Related Parties
IncreaseDecreaseInPrepaidExpensesRelatedParties
12000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-38000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
43000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-730000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4270000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
57000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
7814000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-917000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-509000 USD
CY2022Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
-1000 USD
CY2021Q1 ff Increase Decrease In Accrued Expenses And Other Current Liabilities Related Parties
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilitiesRelatedParties
0 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2269000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-569000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-100000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-139000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10576000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14347000 USD
CY2022Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
2664000 USD
CY2021Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
106000 USD
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
-0 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15601000 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
250000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
28681000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
56000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
977000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
146000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3335000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12828000 USD
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2626000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2624000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2626000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2624000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16537000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4143000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
137521000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
198122000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
120984000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
193979000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
43000 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
52000 USD
CY2022Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
7877000 USD
CY2021Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
0 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
174000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
118000 USD
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 27pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:left;"><b><em style="font: inherit;">1</em></b><b>)</b></p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.8pt;margin-top:0pt;text-align:left;"><b>NATURE OF OPERATIONS AND BASIS OF PRESENTATION</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 15pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;"><i>Organization</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">FutureFuel Corp. (“FutureFuel” or “the Company”), through its wholly-owned subsidiary, FutureFuel Chemical Company (“FutureFuel Chemical”), owns and operates a chemical production facility located on approximately 2,200 acres of land <em style="font: inherit;">six</em> miles southeast of Batesville in north central Arkansas fronting the White River (the “Batesville Plant”). FutureFuel Chemical manufactures diversified chemical products, biobased products composed of biofuels, and biobased specialty chemical products. FutureFuel Chemical’s operations are reported in two segments: chemicals and biofuels.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">The chemical segment manufactures a diversified portfolio of chemical products that are sold to <em style="font: inherit;">third</em> party customers. The majority of the revenues from the chemical segment are derived from the custom manufacturing of specialty chemicals for specific customers.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">The biofuels segment primarily produces and sells biodiesel. FutureFuel Chemical also sells petrodiesel in blends with the Company’s biodiesel and, from time to time, with <em style="font: inherit;">no</em> biodiesel added. </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;"><i>Basis</i> <i>of</i> <i>Presentation</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">The unaudited consolidated financial statements have been prepared by FutureFuel in accordance and consistent with the accounting policies stated in FutureFuel’s <em style="font: inherit;">2021</em> audited consolidated financial statements and should be read in conjunction with these financial statements.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:51pt;margin-right:15pt;margin-top:0pt;text-align:justify;">In the opinion of FutureFuel, all normal recurring adjustments necessary for a fair presentation have been included in the unaudited consolidated financial statements. The unaudited consolidated financial statements have been prepared in compliance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with instructions to Form <em style="font: inherit;">10</em>-Q adopted by the Securities and Exchange Commission (“SEC”). Accordingly the unaudited consolidated financial statements do <em style="font: inherit;">not</em> include all the information and footnotes required by GAAP for complete financial statements, and do include amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The unaudited consolidated financial statements include assets, liabilities, revenues, and expenses of FutureFuel and its direct and indirect wholly owned subsidiaries; namely, FutureFuel Chemical Company; FFC Grain, L.L.C.; FutureFuel Warehouse Company, L.L.C.; and Legacy Regional Transport, L.L.C. Intercompany transactions and balances have been eliminated in consolidation.</p>
CY2022Q1 us-gaap Area Of Land
AreaOfLand
2200 acre
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2213000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
723000 USD
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
11076000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
20780000 USD
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1422000 USD
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
362000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6169000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5944000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10621000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13059000 USD
CY2022Q1 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
5550000 USD
CY2021Q4 ff Accounts Receivable Blenders Tax Credit
AccountsReceivableBlendersTaxCredit
8232000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
55000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
67000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
16790000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.37 pure
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.63 pure
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P36M
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
55000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42261000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41516000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42261000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41516000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35741000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12132000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
931000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
462000 USD
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
16256000 USD
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
30117000 USD
CY2022Q1 us-gaap Inventory Gross
InventoryGross
52928000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
42711000 USD
CY2022Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
15308000 USD
CY2021Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
15791000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q1 us-gaap Inventory Net
InventoryNet
37620000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
26920000 USD
CY2022Q1 us-gaap Effect Of Lifo Inventory Liquidation On Income
EffectOfLIFOInventoryLiquidationOnIncome
2124000 USD
CY2021Q1 us-gaap Effect Of Lifo Inventory Liquidation On Income
EffectOfLIFOInventoryLiquidationOnIncome
0 USD
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
9129000 USD
CY2021Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2625000 USD
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
42751000 USD
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
47109000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3839000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3902000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
163000 USD
CY2021 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
226000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4100000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1765000 USD
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43743243
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43763243
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43743243
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2983000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3347000 USD
CY2022Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1057000 USD
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1912000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
549000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
178000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5164000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6081000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-704000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4387000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054 pure
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.333 pure
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12398000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8773000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43763243
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42261000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41516000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
-7155000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
-10736000 USD
CY2022Q1 ff Inventory Position Estimated Market Value
InventoryPositionEstimatedMarketValue
12000000 USD

Files In Submission

Name View Source Status
0001437749-22-011531-index-headers.html Edgar Link pending
0001437749-22-011531-index.html Edgar Link pending
0001437749-22-011531.txt Edgar Link pending
0001437749-22-011531-xbrl.zip Edgar Link pending
ex_357627.htm Edgar Link pending
ex_357628.htm Edgar Link pending
ex_357629.htm Edgar Link pending
ff-20220331.xsd Edgar Link pending
ff-20220331_cal.xml Edgar Link unprocessable
ff-20220331_def.xml Edgar Link unprocessable
ff-20220331_lab.xml Edgar Link unprocessable
ff-20220331_pre.xml Edgar Link unprocessable
ff20200331_10qimg001.jpg Edgar Link pending
ff20220331_10q.htm Edgar Link pending
ff20220331_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending